| Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID … H Nath, A Mallick, S Roy, S Sukla, S Biswas Computational and Structural Biotechnology Journal 19, 459-466, 2021 | 36 | 2021 |
| Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests H Nath, A Mallick, S Roy, S Sukla, K Basu, A De, S Biswas Journal of Medical Microbiology 70 (6), 001369, 2021 | 35 | 2021 |
| COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test H Nath, A Mallick, S Roy, T Kayal, S Ranjan, S Sengupta, S Sukla, ... International Journal of Infectious Diseases 122, 576-584, 2022 | 9 | 2022 |
| Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections S Roy, S Sukla, A De, S Biswas Scientific reports 12 (1), 1345, 2022 | 6 | 2022 |
| Hepatitis B virus detected in paper currencies in a densely populated city of India: A plausible source of horizontal transmission? P Das, R Supekar, R Chatterjee, S Roy, A Ghosh, S Biswas World Journal of Hepatology 12 (10), 775, 2020 | 2 | 2020 |
| Occult hepatitis B virus infections (often with human herpesvirus 7 co-infection) detected in Pityriasis rosea patients: A pilot study A De, S Roy, S Sukla, A Ansari, S Biswas Indian Journal of Dermatology 62 (6), 598-605, 2017 | 2 | 2017 |
| Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia … S Biswas, S Sukla, S Roy, H Nath, A Mallick International Journal of Infectious Diseases 104, 737, 2021 | 1 | 2021 |
| SARS-CoV-2 has observably higher propensity to accept uracil as nucleotide substitution: Prevalence of amino acid substitutions and their predicted functional implications in … S Roy, H Nath, A Mallick, S Biswas bioRxiv, 2020.10. 07.329771, 2020 | 1 | 2020 |
Dr Subhajit BiswasPrincipal Scientist, CSIR-Indian Institute of Chemical Biology, Kolkata, IndiaVerified email at iicb.res.in
